Meece J (2009) Pharmacokinetics and pharmacodynamics of liraglutide, a long-acting, potent glucagon-like peptide-1 analog
In contrast to its effect on obesity, tirzepatide has shown remarkable results in neuroprotective qualities
A 2026 UK review of the March 2026 NeuroToxicology study showing rosuvastatin disrupts brain microglia , the FDAs 2012 reversible memory loss label change, the 2025 sevenmillionpatient metaanalysis finding statin users have lower dementia risk, the braincholesteroltosynapse mechanism (Mauch 2001), lipophilic vs hydrophilic statins and the bloodbrain barrier, the nocebo effect, NICE NG238 and why reviewing the statin with your GP comes first, not a peptide Read the full review Hormonal Health Men's & Women's Hormonal transitions and cognitive change low testosterone and andropause, menopause, PCOS, thyroid and the maternal brain
This is not a minor suggestion
This hypothesis will be tested using proteomic data from the SELECT trial 36 for the six cardiovascular proteins listed above that were downregulated by semaglutide in STEP 1